174 related articles for article (PubMed ID: 22484568)
21. Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival.
Viganò L; Capussotti L; De Rosa G; De Saussure WO; Mentha G; Rubbia-Brandt L
Ann Surg; 2013 Nov; 258(5):731-40; discussion 741-2. PubMed ID: 24045448
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases.
Wicherts DA; Miller R; de Haas RJ; Bitsakou G; Vibert E; Veilhan LA; Azoulay D; Bismuth H; Castaing D; Adam R
Ann Surg; 2008 Dec; 248(6):994-1005. PubMed ID: 19092344
[TBL] [Abstract][Full Text] [Related]
23. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases.
Makowiec F; Möhrle S; Neeff H; Drognitz O; Illerhaus G; Opitz OG; Hopt UT; zur Hausen A
J Gastrointest Surg; 2011 Jan; 15(1):153-64. PubMed ID: 21061183
[TBL] [Abstract][Full Text] [Related]
25. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
[TBL] [Abstract][Full Text] [Related]
26. Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
Malik H; Khan AZ; Berry DP; Cameron IC; Pope I; Sherlock D; Helmy S; Byrne B; Thompson M; Pulfer A; Davidson B
Eur J Surg Oncol; 2015 Apr; 41(4):499-505. PubMed ID: 25703078
[TBL] [Abstract][Full Text] [Related]
27. Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases.
Pamecha V; Nedjat-Shokouhi B; Gurusamy K; Glantzounis GK; Sharma D; Davidson BR
Dig Surg; 2008; 25(5):387-93. PubMed ID: 19033722
[TBL] [Abstract][Full Text] [Related]
28. Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Sekido H; Togo S
Surgery; 2006 May; 139(5):599-607. PubMed ID: 16701091
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
[TBL] [Abstract][Full Text] [Related]
30. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma.
Rivoire M; De Cian F; Meeus P; Négrier S; Sebban H; Kaemmerlen P
Cancer; 2002 Dec; 95(11):2283-92. PubMed ID: 12436433
[TBL] [Abstract][Full Text] [Related]
31. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
[TBL] [Abstract][Full Text] [Related]
32. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
[TBL] [Abstract][Full Text] [Related]
33. Repeat liver resection for recurrent liver metastases from colorectal cancer.
Thelen A; Jonas S; Benckert C; Schumacher G; Lopez-Hänninen E; Rudolph B; Neumann U; Neuhaus P
Eur J Surg Oncol; 2007 Apr; 33(3):324-8. PubMed ID: 17112697
[TBL] [Abstract][Full Text] [Related]
34. Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review.
Tanaka K; Ichikawa Y; Endo I
Int J Clin Oncol; 2011 Oct; 16(5):452-63. PubMed ID: 21786210
[TBL] [Abstract][Full Text] [Related]
35. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
Reddy SK; Zorzi D; Lum YW; Barbas AS; Pawlik TM; Ribero D; Abdalla EK; Choti MA; Kemp C; Vauthey JN; Morse MA; White RR; Clary BM
Ann Surg Oncol; 2009 Jul; 16(7):1809-19. PubMed ID: 18979139
[TBL] [Abstract][Full Text] [Related]
36. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
[TBL] [Abstract][Full Text] [Related]
37. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
[TBL] [Abstract][Full Text] [Related]
38. [Liver resection after downstaging with neoadjuvant chemotherapy for "unresectable" colorectal metastases].
Frena A; Martin F; La Guardia G; Vezzali N; Bonatti G; Stocker J; Graiff C
Chir Ital; 2004; 56(3):351-7. PubMed ID: 15287631
[TBL] [Abstract][Full Text] [Related]
39. Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases.
Adam R; Miller R; Pitombo M; Wicherts DA; de Haas RJ; Bitsakou G; Aloia T
Surg Oncol Clin N Am; 2007 Jul; 16(3):525-36, viii. PubMed ID: 17606192
[TBL] [Abstract][Full Text] [Related]
40. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
